Kaplan-Meier survival estimates according to the cytogenetic status. (A) Data are shown for OS for CK⁺/MK⁻ AML and CK⁺/MK⁺ AML. (B) Data are shown for OS for the subgroups CK^+/MK⁻/TP53^unaltered, CK⁺/MK⁻/TP53^altered, CK⁺/MK⁺/TP53^unaltered, and CK⁺/MK⁺/TP53^altered.